Biosensors and Molecular Technologies for Cancer Diagnostics -

Biosensors and Molecular Technologies for Cancer Diagnostics

Buch | Softcover
844 Seiten
2016
CRC Press (Verlag)
978-1-138-19853-1 (ISBN)
99,75 inkl. MwSt
Bridging the gap between research and clinical application, Biosensors and Molecular Technologies for Cancer Diagnostics explores the use of biosensors as effective alternatives to the current standard methods in cancer diagnosis and detection. It describes the major aspects involved in detecting and diagnosing cancer as well as the basic elements of biosensors and their applications in detection and diagnostics.

The book addresses cancer molecular diagnostics, including genomic and proteomic approaches, from the perspective of biosensors and biodetection. It explains how to measure and understand molecular markers using biosensors and discusses the medical advantages of rapid and accurate cancer diagnostics. It also describes optical, electrochemical, and optomechanical biosensor technologies, with a focus on cancer analysis and the clinical utility of these technologies for cancer detection, diagnostics, prognostics, and treatment.

Making biosensor technology more accessible to molecular biologists, oncologists, pathologists, and engineers, this volume advances the integration of this technology into mainstream clinical practice. Through its in-depth coverage of a range of biosensors, the book shows how they can play instrumental roles in the early molecular diagnosis of cancer.

Keith E. Herold is an associate professor in the Fischell Department of Bioengineering at the University of Maryland. A fellow of the ASME, Dr. Herold has over 10 years of experience in the analysis and testing of biosensor systems. His current research interests include bioMEMS, microfluidic systems for bioanalytical assays, and heat and mass transfer in bioengineering. Avraham Rasooly is the chief of the Disparities Research Branch at the National Cancer Institute and a member of the Division of Biology in the Center for Devices and Radiological Health at the U.S. Food and Drug Administration.

Introduction. Optical Technologies for Cancer Detection and Diagnostics: Surface Plasmon Resonance. Optical Technologies for Cancer Detection and Diagnostics: Evanescent Wave and Waveguide Biosensors. Optical Technologies for Cancer Detection and Diagnostics: Spectrometry for Cancer Analysis. Optical Technologies for Cancer Detection and Diagnostics: Optical Imaging for Cancer Analysis. Optical Technologies for Cancer Detection and Diagnostics: Fluorescence, Luminescence, Refractive Index Detection Technologies. Optical Technologies for Cancer Detection and Diagnostics: Photoacoustic for Cancer Analysis. Electrochemical Biosensors. Electronic and Magnetic Technologies for Cancer Analysis. Thermometric Sensing. Cantilever-Based Technology. Index.

Erscheinungsdatum
Reihe/Serie Series in Sensors
Zusatzinfo 59 Tables, black and white; 417 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 178 x 254 mm
Gewicht 453 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Naturwissenschaften Biologie
Naturwissenschaften Physik / Astronomie Angewandte Physik
ISBN-10 1-138-19853-6 / 1138198536
ISBN-13 978-1-138-19853-1 / 9781138198531
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99